Literature DB >> 10681058

Expression of chymotrypsin(ogen) in the thioredoxin reductase deficient mutant strain of Escherichia coli AD494(DE3) and purification via a fusion product with a hexahistidine-tail.

G Verheyden1, G Volckaert, Y Engelborghs.   

Abstract

A reliable protocol was designed for fast expression and purification of recombinant chymotrypsin(ogen). The zymogen was overexpressed in soluble form as a (His)6-fusion construct in the cytoplasm of the thioredoxin reductase deficient Escherichia coli strain AD494(DE3). This allowed purification of chymotrypsinogen in a highly selective affinity chromatography capture step using a Ni-NTA column. After activation with enterokinase, the enzymatically active chymotrypsin was purified in a polishing step using a modified soybean trypsin inhibitor agarose column. This expression system and the use of affinity chromatography for capture and polishing, offers an easier and faster route to recombinant chymotrypsin(ogen) than the previously described use of Saccharomyces cerevisiae.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10681058     DOI: 10.1016/s0378-4347(99)00365-5

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  3 in total

1.  A fluorescence stopped-flow kinetic study of the conformational activation of alpha-chymotrypsin and several mutants.

Authors:  Gert Verheyden; Janka Matrai; Guido Volckaert; Yves Engelborghs
Journal:  Protein Sci       Date:  2004-09       Impact factor: 6.725

2.  Simulation of the activation of alpha-chymotrypsin: analysis of the pathway and role of the propeptide.

Authors:  Janka Mátrai; Gert Verheyden; Peter Krüger; Yves Engelborghs
Journal:  Protein Sci       Date:  2004-12       Impact factor: 6.725

3.  Exploration of the activation pathway of Deltaalpha-Chymotrypsin with molecular dynamics simulations and correlation with kinetic experiments.

Authors:  Janka Mátrai; Abel Jonckheer; Eddy Joris; Peter Krüger; Eric Carpenter; Jack Tuszynski; Marc De Maeyer; Yves Engelborghs
Journal:  Eur Biophys J       Date:  2008-08-27       Impact factor: 1.733

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.